ATE315940T1 - Methode zur entfernung von endotoxinen aus impstoffen - Google Patents

Methode zur entfernung von endotoxinen aus impstoffen

Info

Publication number
ATE315940T1
ATE315940T1 AT98937638T AT98937638T ATE315940T1 AT E315940 T1 ATE315940 T1 AT E315940T1 AT 98937638 T AT98937638 T AT 98937638T AT 98937638 T AT98937638 T AT 98937638T AT E315940 T1 ATE315940 T1 AT E315940T1
Authority
AT
Austria
Prior art keywords
solution
endotoxins
vaccines
removal
endotoxin
Prior art date
Application number
AT98937638T
Other languages
English (en)
Inventor
Bridget Kathleen Mapleson
Philip Sizer
Original Assignee
Medeva Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd
Application granted granted Critical
Publication of ATE315940T1 publication Critical patent/ATE315940T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
AT98937638T 1997-07-31 1998-07-31 Methode zur entfernung von endotoxinen aus impstoffen ATE315940T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9716242A GB2327945A (en) 1997-07-31 1997-07-31 Removal of endotoxin from vaccines

Publications (1)

Publication Number Publication Date
ATE315940T1 true ATE315940T1 (de) 2006-02-15

Family

ID=10816795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98937638T ATE315940T1 (de) 1997-07-31 1998-07-31 Methode zur entfernung von endotoxinen aus impstoffen

Country Status (7)

Country Link
US (1) US7226775B2 (de)
EP (1) EP0994722B1 (de)
JP (1) JP4426720B2 (de)
AT (1) ATE315940T1 (de)
DE (1) DE69833256T2 (de)
GB (1) GB2327945A (de)
WO (1) WO1999006067A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995246B1 (en) * 2000-10-19 2006-02-07 Akzo Nobel N.V. Methods for removing suspended particles from soluble protein solutions
WO2005082049A2 (en) * 2004-02-20 2005-09-09 The Board Of Trustees Of The Leland Standford Junior University Artificial biocompatible material as a support for cells in a retinal implant
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US20060079673A1 (en) * 2004-08-02 2006-04-13 Paul Glidden Polynucleotides encoding tRNA synthetase fragments and uses thereof
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
PL212099B1 (pl) * 2007-02-09 2012-08-31 Inst Immunologii I Terapii Doświadczalnej Pan Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie
PT2385763T (pt) * 2009-01-12 2018-07-13 Aerpio Therapeutics Inc Métodos para tratar o síndrome de extravasamento vascular
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CN104370997B (zh) * 2014-09-24 2018-07-31 陈辉 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法
CN108136062B (zh) * 2015-10-02 2020-09-22 伊西康公司 用于处理医疗装置和流体的方法和系统
CN107893058A (zh) * 2017-11-20 2018-04-10 大连雅立峰生物制药有限公司 一种去除疫苗制品中内毒素的方法
CN116987206B (zh) * 2023-07-19 2026-03-24 陕西省微生物研究所 一种去除普鲁兰多糖内毒素的方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315919A (en) * 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
EP0775150B1 (de) * 1994-02-07 1999-04-28 QIAGEN GmbH Verfahren zur abreicherung oder entfernung von endotoxinen

Also Published As

Publication number Publication date
US20010053366A1 (en) 2001-12-20
EP0994722A1 (de) 2000-04-26
JP4426720B2 (ja) 2010-03-03
EP0994722B1 (de) 2006-01-18
DE69833256T2 (de) 2006-09-14
WO1999006067A1 (en) 1999-02-11
GB9716242D0 (en) 1997-10-08
US7226775B2 (en) 2007-06-05
DE69833256D1 (de) 2006-04-06
JP2001511458A (ja) 2001-08-14
GB2327945A (en) 1999-02-10

Similar Documents

Publication Publication Date Title
DE69833256D1 (de) Methode zur entfernung von endotoxinen aus impstoffen
ATE113468T1 (de) Verfahren zur trennung von teilchen nach grösse.
DE69019690D1 (de) Verfahren zur Filtrierung und Reinigung von Wasser.
ATE280322T1 (de) Filterapparat, der gegen das eindringen von wasserlöslichen stoffen unempfindlich ist und filtrationsverfahren
BR0214906A (pt) Sistema de diálise peritoneal para um paciente e método de remoção contìnua de impurezas do sangue de um paciente usando um sistema de diálise peritoneal
ATE160294T1 (de) Verfahren und vorrichtung zum entfernen von dna und viren
DK161786D0 (da) Fremgangsmaade til behandling af biologiske og farmaceutiske produkter for at inaktivere vira og pyrogener
ATE350131T1 (de) Verfahren zur behandlung von fluida
ATE319513T1 (de) Verfahren und vorrichtung zur abtrennung von ionenarten aus einer flüssigkeit
DE69308311D1 (de) Methode zur reinigung von metallhaltigen wässrigen flüssigkeiten und methode zur herstellung eines adsorbens
DE69633561D1 (de) Abgasbehandlungsverfahren
EP0798003A3 (de) Verwendung von strukturierten Tiefenfiltern zur Entfernung von Viren
DE59402684D1 (de) Verfahren zur partiellen modifizierung von porösen, hydrophilen filtermembranen
ATE211927T1 (de) Verfahren zur virusinaktivierung in gegenwart eines polyethers und eines agens
ATE434036T1 (de) Filtrationsverfahren zur trennung von viren
DE69024806D1 (de) Methode der Reinigung von Proteinen
ES2113084T3 (es) Metodo para eliminar al menos un constituyente a partir de una solucion.
ATE126443T1 (de) Verfahren zur abreicherung von viren in lösungen und zur bestimmung der abreicherungsrate von viren.
DE19680576T1 (de) Verfahren zur Behandlung eines Abgasstromes zur Entfernung von NOx
DE69107739D1 (de) Methode zur Entfernung von Kohlenwasserstoffverunreinigungen aus Luft und Wasser.
ATE201387T1 (de) Verfahren zur reinigung von weissen phosphor
DE59503866D1 (de) Verfahren und filter zur entfernung von organischen stoffen und ozon aus gasen
ATE366617T1 (de) Verfahren zur vorfilterung einer proteinlösung
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
DE60015756D1 (de) Verfahren zur gewinnung eines thermostabilen mikroalgenextraktes mit oxidationshemmender- und wundheilender aktivität

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0994722

Country of ref document: EP

REN Ceased due to non-payment of the annual fee